ONC
BeOne Medicines Ltd
93 hedge funds and large institutions have $2.69B invested in BeOne Medicines Ltd in 2017 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.18% less ownership
Funds ownership: 4.84% → 4.66% (-0.18%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
49% less call options, than puts
Call options by funds: $4.01M | Put options by funds: $7.86M
Holders
93
Holding in Top 10
8
Calls
$4.01M
Puts
$7.86M
Top Buyers
| 1 | +$101M | |
| 2 | +$87.9M | |
| 3 | +$24.2M | |
| 4 |
Morgan Stanley
New York
|
+$18.3M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$11.3M |
Top Sellers
| 1 | -$26.6M | |
| 2 | -$24.6M | |
| 3 | -$13.6M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$6.61M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.57M |